Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonography-Reference-Cited by-同舟云学术

Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonography

Published:2004-02 Issue:1 Volume:18 Page:145-156
ISSN:1521-6934
Container-title:Best Practice & Research Clinical Obstetrics & Gynaecology
language:en
Short-container-title:Best Practice & Research Clinical Obstetrics & Gynaecology

Author:

Ferrazzi Enrico,Leone F.P.G

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Medicine

Reference40 articles.

1. Estrogens, progesterone, and endometrial cancer;Jick;Epidemiology,1993

2. The endometrial cancer collaborative group. Estrogen replacement therapy and endometrial cancer risk: unresolved issues;Brinton;Journal of Obstetrics and Gynecology,1993

3. Estrogen–progestin replacement therapy and endometrial cancer;Pike;Journal of the National Cancer Institute,1997

4. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestogen therapy in post-menopausal women;Beresford;Lancet,1997

5. Use of HRT and the subsequent risk of cancer;Beral;Journal of Epidemiology and Biostatistics,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of sonohysterography and hysteroscopy for evaluation of endometrial lesions in tamoxifen treated patients: a systematic review;European Journal of Gynaecological Oncology;2022

2. Hormone replacement therapy—estrogens;Meyler's Side Effects of Drugs;2016

3. Screening for uterine tumours;Best Practice & Research Clinical Obstetrics & Gynaecology;2012-04

4. Abnormal uterine and post-menopausal bleeding in the acute gynaecology unit;Best Practice & Research Clinical Obstetrics & Gynaecology;2009-10

5. SEX HORMONES AND RELATED DRUGS;Meyler's Side Effects of Endocrine and Metabolic Drugs;2009